Dieter Orth

This inventor holds 24 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft MIT Beschraenkter Haftung. Active years: 1976-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dieter Orth. Retrieved from https://idiyas.com/inventor/dieter-orth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 148(Granted Patents)

Company Filing History:

21 out of 1,248

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

3 out of 100

Merck Patent Gesellschaft MIT Beschraenkter Haftung

patents

Years Active: 1976-1986

Loading Chart...

Areas of Expertise:

Thiaprostaglandins

Flavonoid Phosphate Salts

Aminoglycoside Antibiotics

Phenothiazine Derivatives

Lipid Lowering Agents

Hydrocortisone Formulations

Pyrazole Derivatives

Morpholino Compounds

Prostenoic Acid Derivatives

Alkyne Compounds

Anti-Inflammatory Agents

Diketals

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4622316 - 13-thiaprostaglandins having cytoprotective activity (1986-11-11),

2. 4617293 - Flavonoid phosphate salts of aminoglycoside antibiotics (1986-10-14),

3. 4309441 - 13-Thiaprostaglandin derivatives (1982-01-05),

4. 4289774 - Lipid lowering and anti-thrombotic 6-arylpyridazin-3-ones and a process (1981-09-15),

5. 4289768 - Phenothiazine derivatives and a process for their preparation (1981-09-15),

6. 4264585 - Hydrocortisone esters, pharmaceutical formulations containing these and (1981-04-28),

7. 4264584 - Hydrocortisone orthoesters, pharmaceutical formulations thereof and (1981-04-28),

8. 4258047 - Pyrazole derivatives, pharmaceutical formulations thereof (1981-03-24),

9. 4239759 - Morpholino containing compounds, compositions and use thereof (1980-12-16),

10. 4210651 - Thiaprostaglandins (1980-07-01),

11. 4209444 - New prostaglandin-like diketals (1980-06-24),

12. 4196215 - Alkyne compounds and method of use (1980-04-01),

13. 4188403 - Cyclopentan-1-amines (1980-02-12),

14. 4151302 - Araliphatic dihalogen compounds composition and method of use (1979-04-24),

15. 4151294 - Alkynols and process for their preparation (1979-04-24),

Title: The Innovative Contributions of Dieter Orth

Introduction: Dieter Orth, based in Darmstadt, Germany, is a prominent inventor with a remarkable portfolio consisting of 24 patents. His work significantly contributes to the fields of pharmaceuticals and biotechnology, showcasing a commitment to innovation that addresses critical health issues.

Latest Patents: Among his latest innovations, Orth has developed patents for 13-thiaprostaglandins, which exhibit cytoprotective activity. These specific 13-thiaprostaglandins follow a particular formula, providing potential therapeutic benefits. Additionally, he has created flavonoid phosphate salts of aminoglycoside antibiotics. These salts are recognized for their usefulness as sparingly soluble components, allowing for the achievement of depot effects in medicinal applications.

Career Highlights: Dieter Orth's career has been closely linked with significant pharmaceutical entities, particularly the Merck Patent Gesellschaft mit beschränkter Haftung. His contributions to these organizations have paved the way for numerous advancements in drug development and medical therapies, showcasing his expertise in the field.

Collaborations: Throughout his career, Dieter Orth has collaborated with notable colleagues such as Joachim Gante and Manfred Baumgarth. These partnerships have been essential in driving innovative research and development within the pharmaceutical sector.

Conclusion: Dieter Orth's enduring impact on innovation through his extensive patent portfolio illustrates his dedication to the advancement of medical science. His inventions continue to play a pivotal role in enhancing therapeutic options and improving patient outcomes globally.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]